Are you looking for ways how to boost your startup by partnering with relevant corporates? Let us help you. We are looking for innovative startups who are interested in solving business challenges together with our corporate partners.
Scroll down & explore!
Learn more
1. why participate
2. What you get
3. How to join
We understand the unique challenges faced by health and life science startups as we have been investing and helping them grow since 2015. Explore our portfolio here. Examples of two success stories include our exit from bone lengthening medical device company Synoste and leading life sciences robotics and diagnostics automation company Ginolis.
ONE INITIATIVE – SEVERAL FOCUS AREAS
Together with our initiative partners, we are looking for innovative Nordic & Baltic startups that are finding ways to better respond to the prevention and treatment of CARDIOVASCULAR DISEASES and DIABETES.
Our partners are looking for ways to improve: Patient independence, Care quality and cost-effectiveness, Balance in managing care and treatment of chronic diseases, and Utilizing data and digitalization
SUPPORTING YOU THROUGHOUT
Our initiative gives your innovation and product the opportunity to be developed in a real-world setting, that integrates specialized care from hospitals, as well as occupational health and private healthcare providers.
With committed partners focused on ensuring your success, you will have checkpoint meetings and a dedicated advisor board providing valuable growth insights throughout the process. What we expect from you is that you have proof of concept, a genuine interest in co-creating with a corporate, and can dedicate an ample amount of your time to the process.
01
Overall digital solutions for patient care. Solutions could be related to prevention (e.g. identifying risk groups, improving lifestyle modification for prevention and management) or diabetes care and management e.g. remote care and monitoring, two-way communication, and data exchange channels between patient and healthcare professional to improve clinical outcomes of the selected interventions, improvements in health & clinical data management or enhance cost-efficiency in any aspect of the care pathway structure itself.
02
Specific solutions for secondary prevention in digital care of coronary artery patients. Solutions that manage five key parameters proven to decrease the probability of a recurrent event: lipid management, blood glucose, smoking, exercise and blood pressure. In addition, solutions that support self-care and collecting patient-reported outcome measures (PROMs) and elements that improve two-way patient communication as well as patient contact optimization.
Application to our first co-hort ends 11.3.2021
When: 9.4.2021
When: 15.4.-1.9.2021
Medtronic is among the world’s largest medical technology, services and solutions companies. In this cooperation with Innovestor and the CFHCD, we want to find innovative solutions to benefit patients who are living with diabetes.
Sales Manager, Medtronic
Novartis is reimagining medicine to improve and extend people’s lives. In cooperation with Innovestor and CFHCD, we are looking for innovative digital solutions for the prevention and care of cardiovascular diseases.
General Manager, Novartis Finland Oy
The CFHCD’s strategic goal is to be a part of innovative ecosystems that focus on patient care. We want to act as this initiative’s collaborative platform who is at the forefront of utilizing new, influential and innovative patient practices
CEO, Central Finland Health Care District (CFHCD)
As an active Nordic early-stage venture capital investor, we at Innovestor are extremely interested in finding and working with innovative health and life science startups together with our partners, Medtronic, Novartis and the CFHCD.
Managing Partner in charge of Corporate Venturing services at Innovestor
How much does it cost?
What is Innovestor's role in the initiative?
Why should I choose you?
